False-positivity results in rapid antigen tests for SARS-CoV-2: an umbrella review of meta-analyses and systematic reviews

References

• Wu Y, Ho W, Huang Y, et al. SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet. 2020 Mar;395(10228):949–950.
   PubMedGoogle Scholar
• Liu YC, Kuo RL, Shih SR. COVID-19: the first documented coronavirus pandemic in history. Biomed J. 2020 Aug;43(4):328–333.
   PubMed Web of Science ®Google Scholar
• Organization WH Weekly epidemiological update on COVID-19 - 1 February 2022 2022. Available from: (assessed 2022 Feb 1). https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—1-february-2022
   Google Scholar
• Li Z, Yi Y, Luo X, et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol. 2020 Sep;92(9):1518–1524.
   PubMed Web of Science ®Google Scholar
• Scohy A, Anantharajah A, Bodéus M, et al. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J Clin Virol. 2020 Aug;129:104455.
   PubMed Web of Science ®Google Scholar
• DPa CE. Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – sixth update: European Centre for Disease Prevention and Control 2020.
   Google Scholar
• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020 Jan;25(3). https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045.
   Google Scholar
• Bohn MK, Loh TP, Wang CB, et al. IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2. Clin Chem Lab Med. 2020 Oct 7 58(12):2001–2008.
   PubMedGoogle Scholar
• Control CfD. Interim Guidelines for Covid-Antibody Testing. 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html (accessed on 2020 Dec 25).
   Google Scholar
• Albert E, Torres I, Bueno F, et al. Field evaluation of a rapid antigen test (panbio™ COVID-19 Ag rapid test device) for COVID-19 diagnosis in primary healthcare centres. Clin Microbiol Infect. 2021 Mar;27(3):472.e7–472.e10.
   PubMed Web of Science ®Google Scholar
• Blairon L, Wilmet A, Beukinga I, et al. Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: experiences of a general hospital. J Clin Virol. 2020 Aug;129:104472.
   PubMed Web of Science ®Google Scholar
• Aranaz-Andrés JM, Chávez ACF, Laso AM, et al. Analysis of the diagnostic accuracy of rapid antigenic tests for detection of SARS-CoV-2 in hospital outbreak situation. Eur J Clin Microbiol Infect Dis. 2022 Feb;41(2):305–312.
   PubMedGoogle Scholar
• organization Wh. Coronavirus disease (COVID-19) pandemic—emergency use listing procedure (EUL) open for IVDs. Available from: https://extranet.who.int/pqweb/vitro-diagnostics/coronavirus-disease-covid-19-pandemic%E2%80%94-emergency-use-listing-procedure-eul-open,2021 (accessed 2021 Aug 19).
   Google Scholar
• Deerain J, Druce J, Tran T, et al. Assessment of the analytical sensitivity of ten lateral flow devices against the SARS-CoV-2 omicron variant. J Clin Microbiol. 2022Feb; 60(2):e02479–21.
   PubMedGoogle Scholar
• CfDCa P. Interim guidance for antigen testing for SARS-CoV-2. 2020. 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-guidelines.html.
   Google Scholar
• Pray IW. Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2 testing at two university campuses—Wisconsin, September–October 2020. MMWR Morb Mortal Wkly Rep. 2021;3:69. DOI:https://doi.org/10.15585/mmwr.mm7003a1
   Google Scholar
• Albert E, Torres I, Bueno F, et al. Field evaluation of a rapid antigen test (panbio™ COVID-19 Ag rapid test device) for COVID-19 diagnosis in primary healthcare centres. Clin Microbiol Infect. 2021;27(3):472. e7–472. e10.
   Web of Science ®Google Scholar
• Dinnes J, Deeks J, Adriano A, et al. Cochrane COVID-19 Diagnostic Test Accuracy Group. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020 8(8):CD013705.
   Google Scholar
• Reichert F, Enninger A, Plecko T, et al. Pooled SARS-CoV-2 antigen tests in asymptomatic children and their caregivers: screening for SARS-CoV-2 in a pediatric emergency department. Am J Infect Control. 2021;49(10):1242–1246.
   PubMedGoogle Scholar
• Stokes W, Berenger BM, Portnoy D, et al. Clinical performance of the Abbott panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19. Eur J Clin Microbiol Infect Dis. 2021;40(8):1721–1726.
   PubMed Web of Science ®Google Scholar
• Aromataris E, Fernandez R, Godfrey CM, et al. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach Int J Evid Based Health. 2015 Sep;13(3):132-40.
   Google Scholar
• Smith V, Devane D, Begley CM, et al. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol. 2011;11(1):1–6.
   PubMed Web of Science ®Google Scholar
• Aromataris E, Fernandez R, Godfrey CM, et al. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. JBI Evid Implement. 2015;13(3):132–140.
   Google Scholar
• Shea BJ, Hamel C, Wells GA, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol. 2009;62(10):1013–1020.
   PubMed Web of Science ®Google Scholar
• Poole R, Kennedy OJ, Roderick P, et al. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017;359: j5024.
   PubMedGoogle Scholar
• Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358: j4008.
   PubMedGoogle Scholar
• Pieper D, Mathes T, Eikermann M. Can AMSTAR also be applied to systematic reviews of non-randomized studies? BMC Res Notes. 2014;7(1):1–6.
   PubMedGoogle Scholar
• Khalid MF, Selvam K, Jeffry AJN, et al. Performance of rapid antigen tests for COVID-19 diagnosis: a systematic review and meta-analysis. Diagnostics. 2022;12(1):110.
   Google Scholar
• Khandker SS, Nik Hashim NHH, Deris ZZ, et al. Diagnostic accuracy of rapid antigen test kits for detecting SARS-CoV-2: a systematic review and meta-analysis of 17,171 suspected COVID-19 patients. J Clin Med. 2021;10(16):3493.
   PubMed Web of Science ®Google Scholar
• Fujita-Rohwerder N, Beckmann L, Zens Y, et al. Diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children: a systematic review and meta-analysis. BMJ Evid Based Med. 2022 Jan; bmjebm-2021-111828. https://doi.org/10.1136/bmjebm-2021-111828.
   Google Scholar
• Hayer J, Kasapic D, Zemmrich C. Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: a systematic meta-analysis of available data as of November 20, 2020. Inter J Infect Dis. 2021;108:592–602.
   PubMed Web of Science ®Google Scholar
• Wang Y-H, C-C W, Bai C-H, et al. Evaluation of the diagnostic accuracy of COVID-19 antigen tests: a systematic review and meta-analysis. J Chin Med Assoc. 2021;84(11):1028–1037.
   PubMedGoogle Scholar
• Brümmer LE, Katzenschlager S, Gaeddert M, et al. Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: a living systematic review and meta-analysis. PLoS Med. 2021;18(8):e1003735.
   PubMed Web of Science ®Google Scholar
• Lee J, Song JU. Diagnostic accuracy of the cepheid xpert xpress and the Abbott ID now assay for rapid detection of SARS‐CoV‐2: a systematic review and meta‐analysis. J Med Virol. 2021;93(7):4523–4531.
   PubMedGoogle Scholar
• Chen -C-C, S-C L, Bai C-H, et al. Diagnostic accuracy of SARS-CoV-2 antigen tests for community transmission screening: a systematic review and meta-analysis. Int J Environ Res Public Health. 2021;18(21):11451.
   PubMedGoogle Scholar
• Lee J, Song J-U, Shim SR. Comparing the diagnostic accuracy of rapid antigen detection tests to real time polymerase chain reaction in the diagnosis of SARS-CoV-2 infection: a systematic review and meta-analysis. J Clin Virol. 2021;144:104985.
   PubMed Web of Science ®Google Scholar
• Borges LP, Martins AF, de Mello Silva B, et al. Rapid diagnosis of COVID-19 in the first year of the pandemic: a systematic review. Int Immunopharmacol. 2021;101:108144.
   PubMedGoogle Scholar
• Dinnes J, Deeks JJ, Berhane S, et al. Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection. Cochrane Database Syst Rev. 2021;3(3):CD013705.
   Google Scholar
• Corman VM, Haage VC, Bleicker T, et al. Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study. Lancet Microbe. 2021;2(7):e311–e319.
   PubMedGoogle Scholar
• Lim YK, Kweon OJ, Kim HR, et al. Field evaluation of seven SARS-COV-2 antigen assays. J Infect Public Health. 2022;15(2):199–202.
   PubMedGoogle Scholar
• Randriamahazo TR, Andrianarivelo AM, Rakotoarivo AT, et al. Evaluation of antigen-based rapid detection test for the diagnosis of SARS CoV-2 in low-income countries. J Virol Methods. 2022;300:114409.
   PubMedGoogle Scholar
• Onsongo SN, Otieno K, van Duijn S, et al. Performance of a rapid antigen test for SARS-CoV-2 in Kenya. Diagn Microbiol Infect Dis. 2022;102(2):115591.
   PubMedGoogle Scholar
• Jakobsen KK, Jensen JS, Todsen T, et al. Accuracy of anterior nasal swab rapid antigen tests compared with RT‐PCR for massive SARS‐CoV‐2 screening in low prevalence population. Apmis. 2022;130(2):95–100.
   PubMedGoogle Scholar
• Tng DJH, Yin BCY, Cao J, et al. Amplified parallel antigen rapid test for point-of-care salivary detection of SARS-CoV-2 with improved sensitivity. Mikrochim Acta. 2022;189(1):1–12.
   Google Scholar
• Zhan Z, Li J, Cheng ZJ. Rapid antigen test combine with nucleic acid detection: a better strategy for COVID-19 screening at points of entry. J Epidemiol Glob Health. 2022 Mar;12(1):13–15. https://doi.org/10.1007/s44197-021-00018-0.
   Google Scholar
• Polechová J, Johnson K, Payne P, et al. SARS-CoV-2 rapid antigen tests provide benefits for epidemic control - observations from Austrian schools. J Clin Epidemiol. 2022 Jan; 145:14–19.
   Google Scholar
• Burdino E, Cerutti F, Panero F, et al. SARS-CoV-2 microfluidic antigen point-of-care testing in Emergency Room patients during COVID-19 pandemic. J Virol Methods. 2022;299:114337.
   PubMedGoogle Scholar
• Smith DR, Duval A, Zahar JR, et al. Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk. Nat Commun. 2022;13(1):1–10.
   PubMedGoogle Scholar
• Du Z, Pandey A, Bai Y, et al. Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study. Lancet Public Health. 2021;6(3):e184–e191.
   PubMedGoogle Scholar
• Kanji JN, Proctor DT, Stokes W, et al. Multicenter postimplementation assessment of the positive predictive value of SARS-CoV-2 antigen-based point-of-care tests used for screening of asymptomatic continuing care staff. J Clin Microbiol. 2021;59(11):e01411–21.
   Google Scholar
• Reinius M, Zeluf Andersson G, Svedhem V, et al. Towards a new understanding of HIV‐related stigma in the era of efficient treatment‐A qualitative reconceptualization of existing theory. J Adv Nurs. 2021;77(5):2472–2480.
   PubMedGoogle Scholar
• Chopra K, Arora V. Covid-19 and social stigma: role of scientific community. Indian Journal of Tuberculosis. 2020;67(3):284–285.
   PubMedGoogle Scholar
• Wölfl-Duchek M, Bergmann F, Jorda A, et al. Sensitivity and specificity of SARS-CoV-2 rapid antigen detection tests using oral, anterior nasal, and nasopharyngeal swabs: a diagnostic accuracy study. Microbiol Spectr. 2022;10(1):e02029–21.
   Google Scholar
• Zhen W, Smith E, Manji R, et al. Clinical evaluation of three sample-to-answer platforms for detection of SARS-CoV-2. J Clin Microbiol. 2020;58(8):e00783–20.
   PubMed Web of Science ®Google Scholar
• Luo Z, Ye C, Xiao H, et al. Optimization of loop-mediated isothermal amplification (LAMP) assay for robust visualization in SARS-CoV-2 and emerging variants diagnosis. Chem Eng Sci. 2022 Apr; 251:117430. https://doi.org/10.1016/j.ces.2022.117430.
   Google Scholar
• de Puig H, Lee RA, Najjar D, et al. Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants. Sci Adv. 2021;7(32):eabh2944.
   PubMed Web of Science ®Google Scholar
• Agarwal DK, Nandwana V, Henrich SE, et al. Highly sensitive and ultra-rapid antigen-based detection of SARS-CoV-2 using nanomechanical sensor platform. Biosens Bioelectron. 2022;195:113647.
   PubMedGoogle Scholar
• Gans JS, Goldfarb A, Agrawal AK, et al. False-Positive Results in Rapid Antigen Tests for SARS-CoV-2. JAMA. 2022;327:485.
   PubMedGoogle Scholar